Effects of Carboplatin and Cisplatin with Hyperthermia on Blood Cell Counts in Rats
Author Information
Author(s): S. Ohno, F.R. Strebel, L.C. Stephens, Z.H. Siddik, H. Babal, M. Makino, A.R. Khokhar, J.M.C. Bull
Primary Institution: University of Texas Medical School at Houston
Hypothesis
The study examines the severity of thrombocytopenia, anaemia, and leukopenia induced by carboplatin or cisplatin in combination with whole body hyperthermia.
Conclusion
Carboplatin causes more severe myelosuppression than cisplatin when combined with whole body hyperthermia.
Supporting Evidence
- Carboplatin caused a 15% platelet count compared to control by day 8 post-treatment.
- Cisplatin alone produced a higher nadir of platelet counts at 51% of control by day 6.
- Both drugs combined with hyperthermia showed enhanced haematological toxicity.
- Thermal enhancement ratios for carboplatin were 2.0 for thrombocytopenia, 2.8 for anaemia, and 1.9 for leukopenia.
Takeaway
This study found that using heat with certain cancer drugs can make them more harmful to blood cells in rats.
Methodology
Female Fischer 344 rats were treated with carboplatin or cisplatin and subjected to whole body hyperthermia, followed by blood cell count analysis.
Limitations
The study was conducted on rats, which may not fully represent human responses.
Participant Demographics
Female Fischer 344 rats weighing 140 to 170 g.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website